What this study adds
- Co-administering evogliptin and pioglitaozne showed no pharmacokinetic
nor pharmacodynamic interaction.
- Co-administering evogliptin and pioglitaozne may show improved glucose
reduction in type 2 diabetes mellitus patients.
Keywords: evogliptin, pioglitazone, pharmacokinetics,
pharmacodynamics, drug interaction